Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
4.300
-0.190 (-4.23%)
At close: Feb 27, 2026, 4:00 PM EST
4.360
+0.060 (1.40%)
After-hours: Feb 27, 2026, 7:29 PM EST
Evolus Market Cap
Evolus has a market cap or net worth of $278.73 million as of February 27, 2026. Its market cap has decreased by -69.13% in one year.
Market Cap
278.73M
Enterprise Value
390.09M
1-Year Change
-69.13%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $278.73M, an increase of 2.74%. That is a compound annual growth rate of 0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 278.70M | -35.35% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 492.42M |
| SIGA Technologies | 476.93M |
| Eton Pharmaceuticals | 462.60M |
| Canopy Growth | 442.02M |
| Akebia Therapeutics | 339.67M |
| Journey Medical | 285.51M |
| Lifecore Biomedical | 270.32M |
| Aurora Cannabis | 217.67M |